Cumberland Pharmaceuticals shares are trading higher after the company announced the FDA approved expanded labeling for Caldolor to now include use in pre-operative administration. Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care,...
Buy Zone: $3.24- $3.10 SL : Daily Close bellow $3 Target : $6
read our free bi weekly blog on our site-indicators good
see notes below first-percent r upper-aroon crossed